These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28412806)

  • 21. Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.
    Schaffer C; Sarad N; DeCrumpe A; Goswami D; Herrmann S; Morales J; Patel P; Osborne J
    J Lab Autom; 2015 Oct; 20(5):589-600. PubMed ID: 25424384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.
    Somers C; Goossens J; Engelborghs S; Bjerke M
    Biomark Med; 2017 Feb; 11(2):169-178. PubMed ID: 28111962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Amyloid β Signature in the Lens and Its Correlation in the Brain to Aid in the Diagnosis of Alzheimer's Disease.
    Kerbage C; Sadowsky CH; Tariot PN; Agronin M; Alva G; Turner FD; Nilan D; Cameron A; Cagle GD; Hartung PD
    Am J Alzheimers Dis Other Demen; 2015 Dec; 30(8):738-45. PubMed ID: 24526759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease.
    Takeda S; Sato N; Rakugi H; Morishita R
    Mol Biosyst; 2010 Oct; 6(10):1760-6. PubMed ID: 20567751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroscience. Long-awaited technique spots Alzheimer's toxin.
    Helmuth L
    Science; 2002 Aug; 297(5582):752-3. PubMed ID: 12161622
    [No Abstract]   [Full Text] [Related]  

  • 26. Will PET amyloid imaging lead to overdiagnosis of Alzheimer dementia?
    Dubroff JG; Nasrallah IM
    Acad Radiol; 2015 Aug; 22(8):988-94. PubMed ID: 26100192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of misfolded Aβ oligomers for sensitive biochemical diagnosis of Alzheimer's disease.
    Salvadores N; Shahnawaz M; Scarpini E; Tagliavini F; Soto C
    Cell Rep; 2014 Apr; 7(1):261-8. PubMed ID: 24656814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.
    Goldstein LE; Muffat JA; Cherny RA; Moir RD; Ericsson MH; Huang X; Mavros C; Coccia JA; Faget KY; Fitch KA; Masters CL; Tanzi RE; Chylack LT; Bush AI
    Lancet; 2003 Apr; 361(9365):1258-65. PubMed ID: 12699953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Aβ Monomers and Oligomers: Early Diagnosis of Alzheimer's Disease.
    Zhou Y; Liu L; Hao Y; Xu M
    Chem Asian J; 2016 Mar; 11(6):805-17. PubMed ID: 26994700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elucidating the Role of TREM2 in Alzheimer's Disease.
    Ulrich JD; Ulland TK; Colonna M; Holtzman DM
    Neuron; 2017 Apr; 94(2):237-248. PubMed ID: 28426958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
    Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulated Metabolism of the Amyloid-β Protein and Therapeutic Approaches in Alzheimer Disease.
    Kikuchi K; Kidana K; Tatebe T; Tomita T
    J Cell Biochem; 2017 Dec; 118(12):4183-4190. PubMed ID: 28488760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of nano-conjugate on Drosophila for early diagnosis of Alzheimer's disease.
    Ahmed A; Ghallab EH; Shehata M; Zekri AN; Ahmed OS
    Nanotechnology; 2020 Sep; 31(36):365102. PubMed ID: 32045897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of luteinizing hormone and testosterone on beta amyloid (Aβ) accumulation: Animal and human clinical studies.
    Verdile G; Asih PR; Barron AM; Wahjoepramono EJ; Ittner LM; Martins RN
    Horm Behav; 2015 Nov; 76():81-90. PubMed ID: 26122291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. I716F AβPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-β and α-synucleinopathy with Lewy bodies.
    Sieczkowski E; Milenkovic I; Venkataramani V; Giera R; Ströbel T; Höftberger R; Liberski PP; Auff E; Wirths O; Bayer TA; Kovacs GG
    J Alzheimers Dis; 2015; 44(1):103-14. PubMed ID: 25182745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease.
    Catania M; Di Fede G; Tonoli E; Benussi L; Pasquali C; Giaccone G; Maderna E; Ghidoni R; Tagliavini F
    J Alzheimers Dis; 2015; 47(4):877-81. PubMed ID: 26401767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer disease: Preclinical Alzheimer disease - the new frontier.
    Knopman DS
    Nat Rev Neurol; 2016 Nov; 12(11):620-621. PubMed ID: 27713487
    [No Abstract]   [Full Text] [Related]  

  • 39. Early molecular changes in Alzheimer disease: can we catch the disease in its presymptomatic phase?
    Wirz KT; Keitel S; Swaab DF; Verhaagen J; Bossers K
    J Alzheimers Dis; 2014; 38(4):719-40. PubMed ID: 24072070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.